Predictions
Evoke Pharma Inc.
Start price
Target price
Perf. (%)
€26.09
20.08.18
20.08.18
€37.88
06.03.19
06.03.19
-51.87%
06.03.19
06.03.19
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€149.81
20.08.18
20.08.18
€185.00
07.01.19
07.01.19
-19.90%
07.01.19
07.01.19
Some uniques
Small challenges to pay loans and raise capital
Market Leader or Top 3
High valuation
Gladstone Investment Corp.
Start price
Target price
Perf. (%)
€10.84
19.08.18
19.08.18
€19.39
04.11.21
04.11.21
31.88%
05.11.21
05.11.21
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.88
19.08.18
19.08.18
€23.00
04.11.21
04.11.21
-10.77%
05.11.21
05.11.21
CHF Solutions Inc
Start price
Target price
Perf. (%)
?13.89
19.08.18
19.08.18
€18.94
23.08.18
23.08.18
16.27%
23.08.18
23.08.18
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.88
19.08.18
19.08.18
€12.27
05.10.18
05.10.18
3.57%
05.10.18
05.10.18
Netflix Inc.
Start price
Target price
Perf. (%)
€283.07
18.08.18
18.08.18
€360.80
04.09.18
04.09.18
15.91%
04.09.18
04.09.18
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Bank of New York Mellon Cotp.
Start price
Target price
Perf. (%)
€46.68
18.08.18
18.08.18
€50.78
18.02.19
18.02.19
3.48%
18.02.19
18.02.19
Goldman Sachs Group Inc.
Start price
Target price
Perf. (%)
€211.19
18.08.18
18.08.18
€245.60
06.02.19
06.02.19
-15.28%
06.02.19
06.02.19
Delta Air Lines Inc.
Start price
Target price
Perf. (%)
€50.48
18.08.18
18.08.18
€62.63
12.02.19
12.02.19
-9.32%
12.02.19
12.02.19
Colgate-Palmolive Co.
Start price
Target price
Perf. (%)
€60.99
18.08.18
18.08.18
€72.16
18.02.19
18.02.19
-0.44%
18.02.19
18.02.19
Colgate-Palmolive Co.
Start price
Target price
Perf. (%)
€60.83
17.08.18
17.08.18
€72.16
04.09.18
04.09.18
-2.56%
04.09.18
04.09.18
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Procter & Gamble Co.
Start price
Target price
Perf. (%)
€75.63
17.08.18
17.08.18
€90.20
31.08.18
31.08.18
-1.35%
31.08.18
31.08.18
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€151.74
17.08.18
17.08.18
€158.88
05.09.18
05.09.18
-4.46%
05.09.18
05.09.18
Aclaris Therapeutics Inc
Start price
Target price
Perf. (%)
€14.25
17.08.18
17.08.18
€18.31
03.12.18
03.12.18
-40.25%
03.12.18
03.12.18
Could be worthwhile Investment >10% per year
Spark Therapeutics
Start price
Target price
Perf. (%)
€56.17
16.08.18
16.08.18
€70.65
02.10.18
02.10.18
-16.85%
02.10.18
02.10.18